Dawnzera
Payments companies reported to CMS as associated with Dawnzera. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Dawnzera, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Dawnzera
These are the largest totals companies reported as associated with Dawnzera. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Raffi Tachdjian | Santa Monica, CA | Allergy & Immunology | $111,178.32 |
| Autumn Burnette | Washington, DC | Allergy & Immunology (Internal Medicine) | $30,971.14 |
| H James Wedner | Saint Louis, MO | Allergy & Immunology (Internal Medicine) | $30,777.79 |
| Steve Dorman | Jacksonville, FL | Allergy & Immunology | $24,241.62 |
| David Kaufman | Shreveport, LA | Allergy & Immunology | $22,435.97 |
| David Amrol | Columbia, SC | Allergy & Immunology (Internal Medicine) | $21,491.02 |
| Theodore Kelbel | Grand Rapids, MI | Allergy & Immunology | $20,556.11 |
| Nicholas Kolinsky | Knoxville, TN | Allergy & Immunology | $18,485.71 |
| Mark Glaum | Tampa, FL | Allergy & Immunology | $18,207.10 |
| Cristine Radojicic | Durham, NC | Allergy & Immunology | $17,793.48 |
Prescribed Dawnzera?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.